BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients.

Friedlaender, Alex; Vuilleumier, Aurélie; Viassolo, Valeria; Ayme, Aurélie; De Talhouet, Solène; Combes, Jean-Damien; Peron, Julien; Bodmer, Alexandre; Giraud, Sophie; Buisson, Adrien; Bonadona, Valerie; Gauchat-Bouchardy, Isabelle; Tredan, Olivier; Chappuis, Pierre O; Labidi-Galy, S Intidhar.
Breast Cancer Res Treat; 174(3): 775-783, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-30635808